clesrovimab-cfor

clesrovimab-cfor (ENFLONSIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.

ENFLONSIA is a marketed brand name for clesrovimab-cfor. Check FDA Drugs@FDA for the current US label holder and prescribing information.

clesrovimab-cfor has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.